These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 17637938)
1. Spotlight on autoimmune lymphoproliferative syndrome. Ferrer E; Moral MA; Bozzo J Drug News Perspect; 2007 May; 20(4):260-2. PubMed ID: 17637938 [TBL] [Abstract][Full Text] [Related]
2. [Autoimmune lymphoproliferative syndrome: an inherited or a somatic defect of apoptosis]. Rieux-Laucat F Med Sci (Paris); 2006; 22(6-7):645-50. PubMed ID: 16828042 [TBL] [Abstract][Full Text] [Related]
9. Autoimmune lymphoproliferative syndrome (ALPS): a case with congenital onset. Kahwash SB; Fung B; Savelli S; Bleesing JJ; Qualman SJ Pediatr Dev Pathol; 2007; 10(4):315-9. PubMed ID: 17638424 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune lymphoproliferative syndrome: report of two cases and review of the literature. Oren H; Ozkal S; Gülen H; Duman M; Uçar C; Atabay B; Yilmaz S; Kargi A; Irken G Ann Hematol; 2002 Nov; 81(11):651-3. PubMed ID: 12454704 [TBL] [Abstract][Full Text] [Related]
11. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes. Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205 [TBL] [Abstract][Full Text] [Related]
12. The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood. Deutsch M; Tsopanou E; Dourakis SP Clin Rheumatol; 2004 Feb; 23(1):43-4. PubMed ID: 14749982 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood. Auricchio L; Vitiello L; Adriani M; Ferri P; Chiocchetti A; Pettinato G; Racioppi L; Maiuri L; Dianzani U; Pignata C Dermatology; 2005; 210(4):336-40. PubMed ID: 15942224 [TBL] [Abstract][Full Text] [Related]
16. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients. Alvarado CS; Straus SE; Li S; Dale JK; Mann K; Le A; Lauer SJ Pediatr Blood Cancer; 2004 Aug; 43(2):164-9. PubMed ID: 15236285 [TBL] [Abstract][Full Text] [Related]
17. Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders. Sands J; Tuscano JM Autoimmun Rev; 2010 Mar; 9(5):A335-41. PubMed ID: 19914405 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Teachey DT; Obzut DA; Axsom K; Choi JK; Goldsmith KC; Hall J; Hulitt J; Manno CS; Maris JM; Rhodin N; Sullivan KE; Brown VI; Grupp SA Blood; 2006 Sep; 108(6):1965-71. PubMed ID: 16757690 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune lymphoproliferative syndrome type III: an indefinite disorder. Van Der Werff Ten Bosch J; Otten J; Thielemans K Leuk Lymphoma; 2001 Mar; 41(1-2):55-65. PubMed ID: 11342357 [TBL] [Abstract][Full Text] [Related]
20. Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history. Ries F; Ferster A; Rieux-Laucat F; Biwer A; Dicato M Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):271-8. PubMed ID: 20882745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]